Progyny Inc
NASDAQ:PGNY

  • LAST PRICE
    15.1500
  • TODAY'S CHANGE (%)
    0.1500 (1.0000%)
  • Bid / Lots
    14.8300/ 5
  • Ask / Lots
    15.2900/ 30
  • Open / Previous Close
    14.9800 / 15.0000
  • Day Range
    14.9100
    15.4000
  • 52 Week Range
    13.9300
    42.0800
  • Volume
    1,127,667

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Managed Health Care Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
PGNY
Progyny Inc
1.4B
24.2x
---
CLOV
Clover Health Investments Corp
2.1B
-16.4x
---
ALHC
Alignment Healthcare Inc
2.5B
-17.5x
---
IDXG
Interpace Biosciences Inc
10.8M
3.6x
---
MOH
Molina Healthcare Inc
18.7B
16.8x
+12.22%
HUM
Humana Inc
31.4B
22.6x
+9.96%
As of 2024-11-04

Company Information

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Contact Information

Headquarters
1359 BroadwayNEW YORK, NY, United States 10018
Phone
212-888-3124
Fax
302-636-5454

Executives

Executive Chairman of the Board
David Schlanger
President
Michael Sturmer
Chief Executive Officer, Director
Peter Anevski
Chief Financial Officer
Mark Livingston
Executive Vice President, General Counsel, Company Secretary
Allison Swartz

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$1.4B
Revenue (TTM)
$1.1B
Shares Outstanding
90.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.36
EPS
$0.63
Book Value
$5.74
P/E Ratio
24.2x
Price/Sales (TTM)
1.2
Price/Cash Flow (TTM)
20.7x
Operating Margin
6.28%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.